사람이 실험 대상이 되는 의학계에서도 마찬가지 입니다. 1980년에 몇몇 연구자들이 불규칙적인 심장박동 억제 작용을 하는 Lorcainide라는 항부정맥제를 연구를 했는데요, 심장마비를 겪은 환자들에게 불규칙적인 심장박동 리듬을 고칠 수 있는 약을 제공하여 그들의 생존율을 높이고자 했었죠.
It also happens in the very real, flesh and blood of academic medicine. So in 1980, some researchers did a study on a drug called lorcainide, and this was an anti-arrhythmic drug, a drug that suppresses abnormal heart rhythms, and the idea was, after people have had a heart attack, they're quite likely to have abnormal heart rhythms, so if we give them a drug that suppresses abnormal heart rhythms, this will increase the chances of them surviving.